RNS Number : 9941Y
Mulberry Group PLC
02 August 2024
 

For immediate release 02/08/2024

           

            Mulberry Group plc

            Grant of Options

ā€‹

Further to the announcement on 9 July 2024 of the appointment of Andrea Baldo as Chief Executive Officer, Mulberry Group plc ("Mulberry" or the "Company") is pleased to confirm the formal signing of his employment contract, which will take effect from 1 September 2024.

As part of the terms of Mr Baldo's employment contract, on the commencement of his employment on 1 September 2024 he will be granted options over 3,000,000 ordinary shares of 5 pence each in the Company (the "Options").  The Options will be granted pursuant to the Mulberry Group plc 2008 Unapproved Share Option Scheme (the "2008 Scheme"). 

The exercise price for the Options will be set on 1 September 2024 and will be the average closing price of a Mulberry ordinary share on the business days falling during the period of one calendar month prior to 1 September.  The Options will be subject to the 2008 Scheme rules, with one third vesting on each of 3rd, 4th and 5th anniversary of the date of grant, subject to performance conditions being met.

Following the grant of the Options, Andrea Baldo's beneficial interest in the share capital of the Company will consist of 3,000,000 unvested options under the 2008 Scheme.

ā€‹

For further information, please contact:

 

Mulberry Group plc

Charles Anderson (Group Finance Director) 

+44 (0) 20 7605 6793



Houlihan Lokey Advisory Limited (Financial Adviser and NOMAD)

Tim Richardson

 

+44 (0) 20 7484 4040

 



Headland (Public Relations)

Lucy Legh / Joanna Clark

 

+44 (0) 20 3805 4822

 


Peel Hunt LLP (Corporate Broker)

James Thomlinson

+44 (0) 20 7418 8900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFIFVATRIFIIS